London, UK, 9th October 2018 / Sciad Newswire / Following the success of last year's event, Ph
Medical Devices
Wed, 03/10/2018 - 08:30
New funding to support manufacture of transdermal patches for clinical trials
Wed, 07/03/2018 - 07:30
Coventry, UK, 7th March 2018 / Sciad Newswire / Medherant Ltd, a leader in next-generation transdermal drug delivery, is
Thu, 08/02/2018 - 17:15
Brugg AG, Switzerland, 8th February 2018 / Sciad Newswire / Naviswiss, an independent medical technology company specialized in
Mon, 11/12/2017 - 10:00
Coventry, UK, 11th December 2017 / Sciad Newswire / Medherant, a leader in next-generation transdermal drug delivery, ha
Fri, 17/11/2017 - 15:25
Coventry, UK, 17th November 2017 / Sciad Newswire / Medherant is delighted to announce they have been awarded the ‘Excel
Mon, 26/06/2017 - 07:30
Coventry, UK, 26th June 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a nex
Mon, 12/06/2017 - 07:30
Coventry, UK, 12th June 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a nov
Tue, 02/05/2017 - 10:24
London, UK, 2nd May 2017 / Sciad Newswire / Roche Diagnostics UK and Ireland launches the next generation of INR patient self-monitoring meter for patients on war
Mon, 24/10/2016 - 09:00
NALIA Systems, a developer of novel multiplex immunodiagnostic systems for clinical and research applications, announces the expansion of its board following the recent successful £500,000 fund raising.